Absolutely agree.
Transgene seem very confident about the future of TG4010 and that is reinforced by there €10 million joint venture commitment to the development plant in Lyon.
Again I agree that they may have another suitor in the wings. Hence the standard of subscription contributors identified in the share issue.
It bodes well that they have in place a strong and financially backed plan B.
So im happy to watch from the wings as these and other developments unfold.
Add to My Watchlist
What is My Watchlist?
